Amiodarone - Sonus Pharmaceuticals
Alternative Names: S 2646; Tocosol AmiodaroneLatest Information Update: 02 Oct 2021
At a glance
- Originator Sonus Pharmaceuticals
- Class Benzofurans; Class III antiarrhythmics; Heart failure therapies; Small molecules
- Mechanism of Action Beta adrenergic receptor antagonists; KATP channel inhibitors; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ventricular arrhythmias
Most Recent Events
- 04 Apr 2008 Discontinued - Preclinical for Ventricular arrhythmias in USA (unspecified route)
- 01 Jun 2005 No development reported - Preclinical for Ventricular arrhythmias in USA (unspecified route)
- 15 Oct 2002 Preclinical trials in Ventricular arrhythmias in USA (unspecified route)